US · guidance
CMS SOM App. J, Tag W313
§483.450(e)(3) Drugs used for control of inappropriate behavior must not be used until it can
be justified that the harmful effects of the behavior clearly outweigh the potentially harmful
effects of the drugs.
Guidance §483.450(e)(3)
The risk(s) associated with the drug being used is consistent with the type and severity of the
behavior/symptoms it is intended to affect.
At the time the drug was started and incorporated into the IPP, the behaviors were discussed
and presented to team members. It was the documented decision of the team that the
behaviors were of such a severity that pharmacological intervention was required and the
physician was provided with the team information to assist him in his decision to prescribe the
medication.
§483.450(e)(4) Drugs used for control of inappropriate behavior must be- -
§483.450(e)(4)(i) Monitored closely,
History
Rev. 135, Issued: 02-27-15, Effective: 04-27-15, Implementation: 04-27-15
Provenance
- Source
- cms.gov
- Retrieved
- 2026-07-22
- Edition
- som-2026-07-22
- Content hash
ce4a991615c73d0ad3ef362bcad4dc8b55f936de8e4705769e0f2b38bd9fafee
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.